Triple
T9528212
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ministry of Health (Singapore) |
E229815
|
entity |
| Predicate | subordinateAgency |
P23339
|
FINISHED |
| Object |
Health Sciences Authority
The Health Sciences Authority is Singapore’s national regulator for health products and a key agency overseeing blood services, forensic medicine, and related public health and safety functions.
|
E805978
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Health Sciences Authority | Statement: [Ministry of Health (Singapore), subordinateAgency, Health Sciences Authority]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Health Sciences Authority Context triple: [Ministry of Health (Singapore), subordinateAgency, Health Sciences Authority]
-
A.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
B.
Heads of Medicines Agencies
Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
E.
Health Bureau
The Health Bureau is the Hong Kong government department responsible for formulating and overseeing public health, healthcare, and related policy for the territory.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Health Sciences Authority Triple: [Ministry of Health (Singapore), subordinateAgency, Health Sciences Authority]
Generated description
The Health Sciences Authority is Singapore’s national regulator for health products and a key agency overseeing blood services, forensic medicine, and related public health and safety functions.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Health Sciences Authority Target entity description: The Health Sciences Authority is Singapore’s national regulator for health products and a key agency overseeing blood services, forensic medicine, and related public health and safety functions.
-
A.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
B.
Heads of Medicines Agencies
Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
E.
Health Bureau
The Health Bureau is the Hong Kong government department responsible for formulating and overseeing public health, healthcare, and related policy for the territory.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca8479934c81908006d0e6e970ae05 |
completed | March 30, 2026, 2:11 p.m. |
| NER | Named-entity recognition | batch_69cd98b0466081908eb637e2185dea37 |
completed | April 1, 2026, 10:14 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d14c30c6008190b2eff99d74f18070 |
completed | April 4, 2026, 5:36 p.m. |
| NEDg | Description generation | batch_69d14ea0ae408190bcb375a2540c3221 |
completed | April 4, 2026, 5:47 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69d14f13fcdc8190a227d756f1342f16 |
completed | April 4, 2026, 5:49 p.m. |
Created at: March 30, 2026, 8 p.m.